Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher T Su

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
JAMA|October 2, 2019
Limiting the Number of Open Records in an Electronic Health RecordChristopher T Su
JCO Oncology Practice|July 8, 2022
Financial Toxicity Interventions in Hematologic Malignancies Are Timely and NecessaryChristopher T Su
Journal of the American College of Radiology : JACR|December 13, 2022
Defining the Role of the Modern Oncology Provider in Mitigating Financial ToxicityChristopher T Su, Veena Shankaran
Nature Reviews. Clinical Oncology|October 25, 2023
Digital symptom assessment tools: the next frontier in financial toxicity screeningChristopher T Su, Veena Shankaran
Journal of Hematology & Oncology|July 24, 2021
Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyondChristopher T Su, J Christine Ye
JAMA Network Open|March 4, 2024
Medical Debt-An Iatrogenic Epidemic With Mortal ConsequencesChristopher T Su, Scott D Ramsey
The Oncologist|July 24, 2025
Association of Social Vulnerability Index and Chimeric Antigen Receptor T-Cell Therapy Administration, 2018-2023Alireza Boloori, Emisa Nategh, Christopher T Su
Journal of the National Comprehensive Cancer Network : JNCCN|March 28, 2025
HSR25-184: Association of Chimeric Antigen Receptor T-Cell Therapy and Social Vulnerability Index: A National View of Care Delivery PatternsChristopher T Su, Emisa Nategh, Alireza Boloori
JAMA Oncology|October 23, 2025
Can We Use Credit Data to Assess Cancer Financial Hardship?Christopher T Su, Scott D Ramsey, Veena Shankaran
Leukemia & Lymphoma|March 16, 2023
Virtual care for multiple myeloma in the COVID-19 era: interrupted time series analysis of veterans health administration dataChristopher T Su, Jason C Chen, Jeremy B Sussman
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
JAMA|October 2, 2019
Limiting the Number of Open Records in an Electronic Health RecordChristopher T Su
JCO Oncology Practice|July 8, 2022
Financial Toxicity Interventions in Hematologic Malignancies Are Timely and NecessaryChristopher T Su
Journal of the American College of Radiology : JACR|December 13, 2022
Defining the Role of the Modern Oncology Provider in Mitigating Financial ToxicityChristopher T Su, Veena Shankaran
Nature Reviews. Clinical Oncology|October 25, 2023
Digital symptom assessment tools: the next frontier in financial toxicity screeningChristopher T Su, Veena Shankaran
Journal of Hematology & Oncology|July 24, 2021
Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyondChristopher T Su, J Christine Ye
JAMA Network Open|March 4, 2024
Medical Debt-An Iatrogenic Epidemic With Mortal ConsequencesChristopher T Su, Scott D Ramsey
The Oncologist|July 24, 2025
Association of Social Vulnerability Index and Chimeric Antigen Receptor T-Cell Therapy Administration, 2018-2023Alireza Boloori, Emisa Nategh, Christopher T Su
Journal of the National Comprehensive Cancer Network : JNCCN|March 28, 2025
HSR25-184: Association of Chimeric Antigen Receptor T-Cell Therapy and Social Vulnerability Index: A National View of Care Delivery PatternsChristopher T Su, Emisa Nategh, Alireza Boloori
JAMA Oncology|October 23, 2025
Can We Use Credit Data to Assess Cancer Financial Hardship?Christopher T Su, Scott D Ramsey, Veena Shankaran
Leukemia & Lymphoma|March 16, 2023
Virtual care for multiple myeloma in the COVID-19 era: interrupted time series analysis of veterans health administration dataChristopher T Su, Jason C Chen, Jeremy B Sussman
Pageof 3